A State Department drug diplomat heads to Mexico City, the Missouri House gives initial approval to a therapeutic psilocybin study bill, and more.

Shops like this could be popping up soon in Kentucky if a medical marijuana bill passes today. (Creative Commons)

Kentucky Medical Marijuana Bill Advances in House. A bill to legalize medical marijuana in the state, Senate Bill 47, that has already passed the Senate advanced in the House Wednesday just ahead of the final day of the legislative session today. To pass this session, the bill must now clear the House Licensing, Occupations & Administrative Regulations Committee and then pass a House floor vote today. If it does, the bill will go to the desk of Gov. Steve Beshear (D).

Psychedelics

Missouri House Approves Therapeutic Psychedelic Study Bill. The House has voted to approve House Bill 1154, which would require the state to conduct a study on using psilocybin for treating depression, substance use, or in end-of-life care. The bill still needs a final housekeeping vote in the House, but passed overwhelmingly this time. The bill would mandate that the Department of Health and Senior Services (DHSS) provide grants totaling $2 million for the research, subject to lawmakers approving the appropriation. The state would work with a medical center operated by the US Department of Veterans Affairs or with a state university hospital.

Drug Policy

House and Senate Bills Filed to Schedule Xylazine. A bipartisan bill to schedule the animal tranquilizer xylazine as a Schedule III controlled substance was filed in both the House and Senate on Tuesday. The drug, known colloquially as " tranq," is a powerful sedative and the subject of growing concern over its use by opiate and opioid users. While it has opioid-like sedative effects, it is not an opioid, so it does not respond to opiate overdose reversal drugs such as naloxone. It has been associated with soft-tissue wounds and necrosis that can lead to amputation. The DEA recently warned that "xylazine is making the deadliest drug threat our country has ever faced, fentanyl, even deadlier."

Foreign Policy

Assistant Secretary for International Narcotics and Law Enforcement Affairs  Todd D. Robinson Travels to Mexico City. Assistant Secretary for the Bureau of International Narcotics and Law Enforcement Affairs (INL) Todd D. Robinson will travel to Mexico City, Mexico March 28-31 to open the U.S.-Mexico Synthetic Drug Conference and meet with INL’s partners in justice and law enforcement. The conference, co-hosted by INL and the Drug Enforcement Administration (DEA), will take place March 29-30, and will be attended by Assistant Secretary Robinson and Ambassador Kenneth Salazar, with recorded remarks by Secretary of State Antony Blinken.  The conference will focus on strengthening U.S.-Mexico bilateral cooperation to counter the health and security threats posed by illicit synthetic drugs. While in Mexico, Assistant Secretary Robinson will also hold meetings with Mexican government officials to discuss shared security goals.

International

Suspected ELN Militants Kill 9 Colombian Soldiers Near Venezuelan Border. At least nine soldier were killed and nine more injured in an attack on a military post in the state of Norte de Santander Wednesday. The military said it believed leftist rebels of the National Liberation Army (ELN) carried out the attack. The ELN is among a number of armed groups involved in the cocaine trade but has also been involved in peace talks with the government of left-wing President Gustavo Petro. If the ELN is shown to have carried out the attack, that could seriously complicate his effort to bring "total peace" to the country. Whoever carried out the attack is "absolutely far from peace and the people," Petro said. 

A Montana bill would turn back the clock on legal marijuana sales, a House bill to increase fentanyl penalties but also ease scientific research on Schedule I substances wins a House committee vote, and more.

"Whippets"--used nitrous oxide containers. Laughing gas could soon be banned in Britain. (CC)

Federal Marijuana Trafficking Prosecutions Continue to Decline. The US Sentencing Commission reports that federal marijuana trafficking cases continued a long-term decline in 2022. There were about 5,000 federal marijuana cases in 2013, but only 806 last year. The most prosecuted drug was meth, with nearly 10,000 cases. Powder cocaine saw just under 4,000 cases, while fentanyl accounted for around 3,000. There were fewer than 2,000 prosecutions for crack cocaine and for heroin.

Montana Bill Would Dismantle State's Legal Marijuana Industry. A Republican state senator, Keith Regier, has filed a bill that would effectively dismantle the state's legal marijuana industry. The measure, Senate Bill 546, primarily focuses on "eliminating adult-use dispensaries," but also reduces the number of plants adults can grow from two mature plants to one. It also takes aim at the state's medical marijuana program by doubling the state tax on it, and limiting medical marijuana potency and the amount patients could possess. The bill, which has no cosponsors, will get a hearing in the Senate Business, Labor and Economic Affairs Committee on Wednesday.

Drug Policy

House Bill to Increase Fentanyl Penalties, Streamline Marijuana and Psychedelics Research Wins Committee Approval. The House Energy and Commerce Committee last Thursday approved HR 467, the Halt All Lethal Trafficking of Fentanyl Act or HALT Fentanyl Act. The bill places fentanyl-related substances as a class into Schedule I of the Controlled Substances Act. The bill also establishes a new, alternative registration process for Schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. Drug reform advocates generally oppose the bill because it ramps up mandatory minimums for fentanyl offenses even as they would welcome the language easing drug research barriers.

International

British Government Plan to Criminalize Laughing Gas Draws Criticism. Tory Prime Minister Rishi Sunak on Monday unveiled a plan to tackle "anti-social behavior" that includes criminalizing the possession of nitrous oxide (laughing gas) as a Class C drug. In doing so, he rejected the recommendation of the Advisory Council on the Misuse of Drugs, which recently said it should not be banned. It also drew criticism from the scientific non-profit Drug Science, which said a ban is "is completely disproportionate" and "would likely deliver more harm than good." But Home Secretary Suella Braverman told Parliament there was still "emerging evidence that [nitrous oxide] does cause serious harm to health and wellbeing" and that the measure "put an end to hordes of youths loitering in and littering parks with empty canisters." Labor, for its part, criticized the government crackdown as "too little, too late," but said it supported the nitrous oxide ban. 

A bill banning minors from buying Delta-8 THC products is signed into law in Kentucky, a bill banning medical marijuana use by pregant or breast-feeding women is signed into law in South Dakota, and more.

Zaza, a product containing the opiate-like drug tianeptine, is now banned in Kentucky. (Creative Commons)

Kentucky Governor Signs Bill Barring Minors from Buying Delta-8 THC Products. Gov. Andy Beshear (D) on Thursday signed into law a bill making it illegal for people under 21 to buy products containing delta-8 THC, a naturally occurring compound typically extracted from hemp-derived CBD that has mild psychoactive effects compared to delta-9 THC and is known colloquially as "marijuana lite." House Bill 544 passed the legislature unanimously directs the Cabinet for Health and Family Services to "immediately begin the process of regulating delta-8 tetrahydrocannabinol and any other hemp-derived substances." It also prohibits "the sale, gift, or sother transfer of possession" of the products to people under 21 years old, and bars anyone under that age from possessing them.

Medical Marijuana

Oklahoma Senate Passes Pack of Medical Marijuana Bills. The Senate on Thursday approved multiple bills aimed at tightening regulations on the state's medical marijuana industry. Senate Bill 264 allows regulators to use ‘secret shoppers’ to discover businesses not following medical marijuana rules and laws. Senate Bill 437 directs the Oklahoma Health Care Authority (OHCA) to develop a registry of physicians following the agency’s original and continuing medical education requirements. All medical marijuana business employees will also need to complete the education requirements. Senate Bill 439  requires regulators to provide a list of qualifying medical conditions to receive a medical marijuana patient license. Physicians will need to hold in-person exams of all license applicants unless the patient is certified as home-bound. It also requires that the two recommending physicians able to prescribe medical marijuana for minors to not be located at the same physical address. Senate Bill 440 limits the THC potency of medical marijuana and related products sold in dispensaries to no more than 1,000 mg of delta-9 THC per package for edible products. Senate Bill 645 requires that any medical marijuana flower, trim, shake, kief, medical marijuana product, or other flower-based product not labeled as a concentrate, sold by licensed processors and commercial growers to licensed dispensaries be pre-packaged and weigh at least half of a gram and no more than three ounces. Flowers are allowed to be packaged in nonopaque materials. Senate Bill 813 allows the state to run a quality assurance lab to direct compliance testing of medical marijuana businesses. The bills now go to the House.

South Dakota Governor Signs Trio of Medical Marijuana Bills. Gov. Kristi Noem (R) on Thursday signed into law three bills dealing with medical marijuana: House Bill 1053 bars pregnant or breast-feeding women from being certified for medical marijuana. House Bill 1132 revises the duties of the Medical Marijuana Oversight Committee (MMOC), adding that the committee shall make recommendations regarding and medical and clinical aspects of the medical cannabis program. House Bill 1150 waives patient fees in some circumstances and requires practitioners to certify whether they have previously certified a patient for medical marijuana.

Drug Policy

Kentucky Governor Signs Emergency Order Making "Gas Station Heroin" a Controlled Substance. Gov. Andy Beshear (D) on Thursday issued an emergency order classifying products containing tianeptine, a previously unregulated drug colloquially known as "gas station heroin," as a Schedule I controlled substance under state law. The drug produces opioid-like effects and is sold in products such as ZaZa, Tianna, TD Red and Pegasus. "Today, Kentucky became a safer place," said Gov. Beshear. "Until now, someone looking for a heroin-like high could walk into certain places or buy this harmful product online. We’re committed to protecting Kentuckians from this kind of harm, and if someone is struggling with abuse, we’re here to help."

More than 60 years after coca and cocaine were banned internationally under the Single Convention on Narcotic Drugs, 1961, and more than a half-century since the commencement of the modern war on drugs under US President Richard Nixon, cocaine is more popular and more prevalent than ever before. That is according to the United Nations Office on Drugs and Crime (UNODC), which just provided the evidence in its new report, The Global Report on Cocaine 2023.

Despite a half-century of the modern war on drugs, the cocaine trade is booming. (Creative Commons)

"The COVID-19 pandemic had a disruptive effect on drug markets," UNODC found. "With international travel severely curtailed, producers struggled to get their product to market. Night clubs and bars were shut as officials ramped up their attempts to control the virus, causing demand to slump for drugs like cocaine that are often associated with those settings. However, the most recent data suggests this slump has had little impact on longer-term trends. The global supply of cocaine is at record levels. Almost 2,000 tons was produced in 2020, continuing a dramatic uptick in manufacture that began in 2014, when the total was less than half of today’s levels."

UNODC found that cultivation of coca, the plant precursor to cocaine, increased a whopping 35 percent between 2020 and 2021, a record high and the largest year-over-year increase since 2016. The production of cocaine itself has been boosted by innovations in coca cultivation leading to larger yields and innovations in converting the plant into cocaine, also leading to larger yields.

That supply increase "has been matched by a similar swelling in demand, with many regions showing a steady rise in cocaine users over the past decade," UNODC wrote.

That is a product that is looking for and finding new markets, leading UNODC analysts to warn of continued growth in consumption.

"The surging global cocaine market has the potential to trigger large expansions in new regions where cocaine use has been limited in the past, especially Africa and Asia,"  said Chloé Carpentier, Chief of the Drug Research Section, Research and Trend Analysis Branch at UNODC.

"There has been a continuing growth in demand, with most regions showing steadily rising numbers of users over the past decade," the report noted. "Although these increases can be partly explained by population growth, there is also a rising prevalence of cocaine use."

Cocaine use remains a largely Western phenomenon, but that is changing. North America constituted 30 percent of global demand in 2020, with South America and the Caribbean accounting for 24 percent, and Western Europe accounting for 21 percent. Africa was a distant fourth at nine percent.

But Africa is increasingly involved in the cocaine trade, leading to a "serious risk" of increased consumption there, UNODC warned. "The role of Africa, especially West and Central Africa, as a transit zone for cocaine on its way to markets in Europe has picked up substantially since 2019," the report said. "Both the total quantity seized in Africa and the number of large seizures appear to have reached record levels."

One impact of the pandemic was that the reduction is passenger flights lessened traffickers' ability to use drug mules, and UNODC found that the use of international parcel services for cocaine smuggling surged in response.

"Some countries in West Africa noted a significant increase in [parcel and courier] services to smuggle small quantities of cocaine to Europe and beyond. In Costa Rica, smaller quantities of cocaine were being mailed to Asia, Africa and Europe concealed in goods such as books, religious images, and vehicle spare parts,"  the report said.

"The pandemic may have accelerated the trend, but traffickers had already been increasing their use of international mail services to get cocaine into Europe," it said. "Evidence from Spain and Argentina points to a longer-term decline in the use of drug mules on passenger flights. Both countries recorded instances of larger shipments being concealed in unaccompanied luggage."

While the report discussed increased international cooperation to combat the cocaine trade, there is little indication so far that international cooperation has been able to stop it. In fact, the report itself suggests the opposite. But there is no consideration given to alternatives to the cocaine prohibition regime.